HeyJaredJCO Precision Oncology Conversations
JCO Precision Oncology Conversations is a monthly podcast featuring conversations with authors of clinically relevant and significant articles published in the JCO Precision Oncology journal.
- Indexed episodes, last 90 days
- 5
- Latest publication
- Sep 16, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 15, 2026
Latest episodes
A Decade of Data: JCO PO and the TAPUR Study (opens the original)
Read excerpt
JCO PO Editor-in-Chief Emeritus Dr. James Ford and Founding PI, ASCO TAPUR Study , Dr. Richard Schilsky discuss the 10-year anniversary of the Targeted Agent and Profiling Utilization Registry (TAPUR)™ Study and its relationship with the journal. Host Dr. Rafeh Naqash and guests discuss the inception/history of the TAPUR study, its future, and advances in precision medicine over the past decade. LINK TO FULL TRANSCRIPT
JCO PO Article Insights: Breast Neuroendocrine Carcinoma Beyond Histology (opens the original)
Read excerpt
In this JCO PO Article Insights episode, host Carolyn Lineen summarizes the article, " Breast Neuroendocrine Carcinoma: Molecular Insights Beyond Histology " by Schwartz and colleagues. LINK TO FULL TRANSCRIPT
cfDNA Epigenetics for Toxicity Monitoring (opens the original)
Read excerpt
JCO PO authors Dr. James Hadfield, Dr. Grace Yiqing Zhao, and Dr. Julia Elvin at AstraZeneca share insights into the JCO PO article, " Beyond Circulating Tumor DNA for Efficacy: Can We Use Cell-Free DNA to Detect and Monitor Toxicity Signals? " Host Dr. Rafeh Naqash and guests discuss emerging evidence that cfDNA methylation profiling provides sensitive, specific signals of tissue injury across multiple organs and clinical contexts. LINK TO FULL TRANSCRIPT
JCO PO Article Insights: Clinical ctDNA Testing in Advanced Pediatric Solid Tumors (opens the original)
Read excerpt
In this episode of JCO PO: Article Insights, host Jiasen He summarizes the article, " Clinical Liquid Biopsy Testing for Detection of Actionable Genomic Alterations in Children and Young Adults With Advanced Solid Tumors on the GAIN Study ," by Roberts and colleagues. LINK TO FULL TRANSCRIPT
ALK+ Squamous and Adenosquamous NSCLC (opens the original)
Read excerpt
JCO PO author Dr. Emily Miao at Mass General Brigham Cancer Institute shares insights into the JCO PO article, " Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced ALK-Rearranged Squamous and Adenosquamous Non–Small Cell Lung Cancers ." Host Dr. Rafeh Naqash and Dr. Miao discuss the clinicogenomic characteristics and treatment outcomes of patients with ALK+ squamous and adenosquamous lung cancers and how these outcomes compare to those of patients with ALK+ adenocarc
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.